Evidence to Implicate Early Modulation of Interleukin-1β Expression in the Neuroprotection Afforded by 17β-Estradiol in Male Rats Undergone Transient Middle Cerebral Artery Occlusion

International Review of Neurobiology

Volumn 82, Issue , 2007, Pages 357-372

  Chiappetta, Olga ^a   Gliozzi, Micaela ^b   Siviglia, Elisa ^b   Amantea, Diana ^a   Morrone, Luigi A ^a   Berliocchi, Laura ^a   Bagetta, G ^a   Corasaniti, M Tiziana ^b,c  

^a UNIVERSITY OF CALABRIA   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; CYTOCHROME C; DRUG DERIVATIVE; ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; INTERLEUKIN 1BETA; NEUROPROTECTIVE AGENT;

ANIMAL; BIOSYNTHESIS; BRAIN ISCHEMIA; CELL FRACTIONATION; CEREBRAL ARTERY DISEASE; CYTOSOL; DRUG ANTAGONISM; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; RAT; REVIEW; WESTERN BLOTTING; WISTAR RAT;

ANIMALS; BLOTTING, WESTERN; BRAIN ISCHEMIA; CYTOCHROMES C; CYTOSOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRADIOL; ESTROGEN ANTAGONISTS; INFARCTION, MIDDLE CEREBRAL ARTERY; INTERLEUKIN-1BETA; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; RECEPTORS, ESTROGEN; SUBCELLULAR FRACTIONS;

EID: 34547291144     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(07)82019-8     Document Type: Review

References (68)

1. Alkayed N.J., Harukuni I., Kimes A.S., London E.D., Trayatman R.J., and Hurn P.D. Gender-linked brain injury in experimental stroke. Stroke 29 (1998) 159-165
2. Alkayed N.J., Goto S., Sugo N., Joh H.-D., Klaus J., Crain B.J., Bernard O., Traystman R.J., and Hurn P.D. Estrogen and Bcl-2: Gene induction and effect of transgene in experimental stroke. J. Neurosci. 21 (2001) 7543-7550
3. Amantea D., Russo R., Bagetta G., and Corasaniti M.T. From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens. Pharmacol. Res. 52 (2005) 119-132
4. Babu P.P., Yoshida Y., Su M., Segura M., Kawamura S., and Yasui N. Immunohistochemical expression of Bcl-2, Bax and cytochrome c following focal cerebral ischemia and effect of hypotermia in rat. Neurosci. Lett. 291 (2000) 196-200
5. Bagetta G., Chiappetta O., Amantea D., Iannone M., Rotiroti D., Costa A., Nappi G., and Corasaniti M.T. Estradiol reduces cytochrome c translocation and minimizes hippocampal damage caused by transient global ischemia in rat. Neurosci. Lett. 368 (2004) 87-91
6. Bogdanov M.B., Ferrante R.J., Mueller G., Ramos L.E., Martinou J.C., and Beal M.F. Oxidative stress is attenuated in mice overexpressing Bcl-2. Neurosci. Lett. 262 (1999) 33-36
7. Buttini M., Sauter A., and Boddeke H. Induction of interleukin-1beta mRNA after focal ischemia in the rat. Mol. Brain Res. 23 (1994) 126-134
8. Chen D.F., Schneider G.E., Martinou J.C., and Tonegawa S. Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature 385 (1997) 434-439
9. Corasaniti M.T., Turano P., Bilotta A., Malorni W., Stingaro A.R., Nisticò R., Finazzi-Agrò A., and Bagetta G. Evidence that increases of mitochondrial immunoreactive IL-1β by HIV-1 gp120 implicate in situ cleavage of pro-IL-1β in the neocortex of rat. J. Neurochem. 78 (2001) 611-618
10. Corasaniti M.T., Amantea D., Russo R., Piccirilli S., Leta A., Corazzari M., Nappi G., and Bagetta G. 17β-Estradiol reduces neuronal apotosis induced by HIV-1 gp120 in the neocortex of rat. NeuroToxicol. 26 (2005) 893-903
11. Davies C.A., Loddick S.A., Toulmond S., Stroemer R.P., Hunt J., and Rothwell N.J. The progression and topographic distribution of interleukin-1 beta expression after permanent middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 19 (1999) 87-98
12. Desagher S., and Martinou J.C. Mitochondria as the central control point of apoptosis. Trends Cell Biol. 10 (2000) 369-377
13. Dispersyn G., Nuydens R., Connors R., Borgers M., and Geerts H. Bcl-2 protects against FCCP-induced apoptosis and mitochondrial membrane potential depolarization in PC12 cells. Biochim. Biophys. Acta 1428 (1999) 357-371
14. Dubal D.B., Kashon M.L., Pettigrew L.C., Ren J.M., Finklestein S.P., Ran S.W., and Wise P.M. Estradiol protects against ischemic injury. J. Cereb. Blood Flow Metab. 18 (1998) 1253-1258
15. Dubal D.B., Shughrue P.J., Wilson M.E., Merchenthaler I., and Wise P.M. Estradiol modulates Bcl-2 in cerebral ischemia: A potential role for estrogen receptor. J. Neurosci. 19 (1999) 6385-6396
16. Evans M.J., Lai K., Shaw L.J., Harnish D.C., and Chadwick C.C. Estrogen receptor α inhibits IL-1β induction of gene expression in the mouse liver. Endocrinology 143 (2002) 2559-2570
17. Falkeborn M., Persson I., Terent A., Adami H.O., Lithell H., and Bergstrom R. Hormone replacement therapy and the risk of stoke. Follow-up of a population-based cohort in Sweden. Arch. Intern. Med. 153 (1993) 1201-1209
18. Fukuda K., Yao H., Ibayashi S., Nakahara T., Uchimura H., Fujishima M., and Hall E.D. Ovariectomy exacerbates and estrogen replacement attenuates photothrombotic focal ischemic brain injury in rats. Stroke 31 (2000) 155-160
19. Garcia J.H., Liu K.F., and Relton J.K. Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am. J. Pathol. 147 (1995) 1477-1486
20. Garcia-Segura L.M., Cardona-Gomez P., Naftolin F., and Chowen J.A. Estradiol upregulates Bcl-2 expression in adult brain neurons. NeuroReport 9 (1998) 593-597
21. Garcia-Segura L.M., Azcoitia I., and Don Carlos L.L. Neuroprotection by estradiol. Prog. Neurobiol. 63 (2001) 29-60
22. Gladstone D.J., Black S.E., Hakim A.M., and Heart and Stroke Foundation of Ontario Centre of Excellence in Stroke Recovery. Toward wisdom from failure. Lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 33 (2002) 2123-2136
23. Hagan P., Poole S., Bristow A.F., Tilders F., and Silverstein F.S. Intracerebral NMDA injection stimulates production of interleukin-1β in perinatal rat brain. J. Neurochem. 67 (1996) 2215-2218
24. Hara H., Friedlander R.M., Gagliardini V., Ayata C., Fink K., Huang Z., Shimizu-Sasamata M., Yuan J., and Moskowitz M.A. Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc. Natl. Acad. Sci. USA 94 (1997) 2007-2012
25. Holm K., and Isacson O. Factors intrinsic to the neuron can induce and maintain its ability to promote axonal outgrowth: A role for Bcl-2?. Trends Neurosci. 22 (1999) 269-273
26. Howard S., Bottino C., Brooke S., Cheng E., Giffard R.G., and Sapolsky R. Neuroprotective effects of bcl-2 overexpression in hippocampal cultures: Interactions with pathways of oxidative damage. J. Neurochem. 83 (2002) 914-923
27. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., and Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280 (1998) 605-613
28. Hurn P.D., and Brass L.M. Estrogen and stroke: A balanced analysis. Stroke 34 (2003) 338-341
29. Jilka R.L., Hangoc G., Girasole G., Passeri G., Williams D.C., Abrams J.S., Boyce B., Broxmeyer H., and Manolagas S.C. Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science 257 (1992) 88-91
30. Johnson A.B., Bake S., Lewis D.K., and Sohrabji F. Temporal expression of IL-1b protein and mRNA in the brain after systemic LPS injection is affected by age and estrogen. J. Neuroimmunol. 174 (2006) 82-91
31. Kajta M., and Beyer C. Cellular strategies of estrogen-mediated neuroprotection during brain development. Endocrine 21 (2003) 3-9
32. Kajta M., Trotter A., Lason W., and Beyer C. Impact of 17β-estradiol on cytokine-mediated apoptotic effects in primary hippocampal and neocortical cell cultures. Brain Res. 1116 (2006) 64-74
33. Kim H.E., Yoon S.Y., Lee J.E., Choi W.S., Jin B.K., Oh T.H., Markelonis G.J., Chun S.Y., and Oh Y.J. MPP(+) downregulates mitochondrially encoded gene transcripts and their activities in dopaminergic neuronal cells: Protective role of Bcl-2. Biochem. Biophys. Res. Commun. 286 (2001) 659-665
34. Kroemer G., and Reed J.C. Mitochondrial control of cell death. Nat. Med. 6 (2000) 513-519
35. Legos J.J., Whitmore R.G., Erhardt J.A., Parsons A.A., Tuma R.F., and Barone F.C. Quantitative changes in interleukin proteins following focal stroke in the rat. Neurosci. Lett. 282 (2000) 189-192
36. Li F., Omori N., Sato K., Jin G., Nagano I., Manabe Y., Shoji M., and Abe K. Coordinate expression of survival p-ERK and proapoptotic cytochrome c signals in rat brain neurons after transient MCAO. Brain Res. 958 (2002) 83-88
37. Li H., Colbourne F., Sun P., Zhao Z., Buchan A.M., and Iadecola C. Caspase inhibitors reduce neuronal injury after focal but not global cerebral ischemia in rats. Stroke 31 (2000) 176-182
38. Li P., Nijhawan D., Budihardjo I., Srinvasula S.M., Ahmad M., Alnemri E.S., and Wang X. Cytochrome x and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91 (1997) 479-489
39. Liu T., McDonnell P.C., Young P.R., White R.F., Siren A.L., Hallenbeck J.M., Barone F.C., and Feurerstein G.Z. Interleukin-1-beta messenger RNA expression in ischemic rat cortex. Stroke 24 (1993) 1746-1751
40. Liu X., Kim C.N., Yang J., Jemmerson R., and Wang X. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 86 (1996) 147-157
41. Longa E.Z., Weinstein P.R., Carlson S., and Cummins R. Reversible middle cerebral artery occlusion without craniotomy in rats. Stroke 20 (1989) 84-91
42. Longstreth W.T., Nelson L.M., Koepsell T.D., and van Belle G. Subarachnoid hemorrhage and hormonal factors in women. A population-based case-control study. Ann. Intern. Med. 121 (1994) 168-173
43. Maggi A., Ciana P., Belcredito S., and Vegeto E. Estrogens in the nervous system: Mechanisms and nonreproductive functions. Annu. Rev. Physiol. 66 (2004) 291-313
44. Matejuk A., Adlard K., Zamora A., Silverman M., Vandenbark A.A., and Offner H. 17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis. J. Neurosci. Res. 65 (2001) 529-542
45. Mulcahy N., Ross J., Rothwell N.J., and Loddick S.A. Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischemia in the rat. Br. J. Pharmacol. 140 (2003) 471-476
46. Nordell V.L., Scarborough M.M., Buchanan A.K., and Sohrabji F. Differential effects of estrogen in the injured forebrain of young adult and reproductive senescent animals. Neurobiol. Aging 24 (2003) 733-743
47. Paganini-Hill A. Estrogen replacement therapy and stroke. Prog. Cardiovasc. Dis. 38 (1995) 223-242
48. Paganini-Hill A., Ross R.K., and Henderson B.E. Postmenopausal oestrogen treatment and stroke: A prospective study. BMJ 297 (1988) 519-522
49. Polan M.L., Loukides J., Nelson P., Carding S., Diamond M., Walsh A., and Bottomly K. Progesterone and estradiol modulate interleukin-1 beta messenger ribonucleic acid levels in cultured human peripheral monocytes. J. Clin. Endocrinol. Metab. 69 (1989) 12200-12206
50. Reed J.C. Apoptosis-based therapy. Nat. Rev. Drug Discov. 1 (2002) 111-121
51. Relton J.K., and Rothwell N.J. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res. Bull. 29 (1992) 242-246
52. Relton J.K., Martin D., Thompson R.C., and Russell D.A. Peripheral administration of interleukin-1 receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat. Exp. Neurol. 138 (1996) 206-213
53. Rothwell N. Interleukin-1 and neuronal injury: Mechanisms, modification, and therapeutic potential. Brain Behav. Immun. 17 (2003) 152-157
54. Rusa R., Alkayed N.J., Crain B.J., Traystman R.J., Kimes A.S., London E.D., Klaus J.A., and Hurn P.D. 17β-estradiol reduces stroke injury in estrogen-deficient female animals. Stroke 30 (1999) 1665-1670
55. Schmidt R., Fazekas F., Reinhart B., Kapeller P., Fazekas G., Orfenbacher S., Eber B., Schumacher M., and Freidl W. Estrogen replacement therapy in older women: A neuropsychological and brain MRI study. J. Am. Geriatr. Soc. 44 (1996) 1307-1313
56. Simon J.A., Hsia J., Cauley J.A., Richard C., Harris F., Fong J., Barrett-Connor E., Hulley S.B., and the HERS Research Group. Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-Progestin Replacement Study (HERS). Circulation 103 (2001) 638-642
57. Simpkins J.W., Rajekumar G., Zhang Y.Q., Simpkins C.E., Greenwald D., Yu C.J., Bodor N., and Day A.L. Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J. Neurosurg. 87 (1997) 724-730
58. Sims N.R., and Anderson M.F. Mitochondrial contribution to tissue damage in stroke. Neurochem. Int. 40 (2002) 511-526
59. Slee E.A., Harte M.T., Kluck R.M., Wolf B.B., Casiano C.A., Newmeyer D.D., Wang H.G., Reed J.C., Nicholson D.W., Alnemri E.S., Green D.R., and Martin S.J. Ordering the cytochrome c-initiates caspase cascade: Hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 144 (1999) 281-292
60. Sudo S., Wen T.C., Desaki J., Matsuda S., Tanaka J., Arai T., Maeda N., and Sakanaka M. β-estradiol protects hippocampal CA1 neurons against transient forebrain ischemia in gerbil. Neurosci. Res. 29 (1997) 345-354
61. Sugawara T., Fujimura M., Morita-Fujimura Y., Kawase M., and Chan P.H. Mitochondrial release of cytochrome c corresponds to the selective vulnerability of hippocampal CA1 neurons in rats after transient global cerebral ischemia. J. Neurosci. 19 (1999) 1-6
62. Toung T.J., Traystman R.J., and Hurn P.D. Estrogen-mediated neuroprotection after experimental stroke in male rats. Stroke 29 (1998) 1666-1670
63. Viscoli C.M., Brass L.M., Kernan W.N., Sarrel P.M., Suissa S., and Horwitz R.I. A clinical trial of estrogen-replacement therapy after ischemic stroke. N. Engl. J. Med. 345 (2001) 1243-1249
64. Wang X.K., Yue T.L., Barone F.C., White R.F., Gagnon R.C., and Feuerstein G.Z. Concomitant cortical expression of TNF-α and IL-1β mRNAs follows early response gene expression in transient focal ischemia. Mol. Chem. Neuropathol. 23 (1994) 103-114
65. Yamasaki Y., Matsuura N., Shizuhara H., Onodera H., and Itoyama Y.K.K. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in the rats. Stroke 26 (1995) 676-681
66. 2+ channel antagonists suppress the release of cytochrome c and the expression of procaspase-3 in rat hippocampus after global brain ischemia. Neurosci. Lett. 328 (2002) 265-268
67. Zhang Z., Chopp M., Goussev A., and Powers C. Cerebral vessels express interleukin 1 beta after focal cerebral ischemia. Brain Res. 784 (1998) 210-217
68. Zhao H., Yenari M.A., Cheng D., Sapolsky R.M., and Steinberg G.K. Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. J. Neurochem. 85 (2003) 1026-1036